D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

RAPP holding history

Rapport Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RAPP overview All 13F holders of RAPP Full Q2 2026 holdings

Shares (Q2 2026): 214,831
Value: $8.95M
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of RAPP by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	214,831	$8.95M	<0.1%	+39,382+22.4%	Added	Holders
Q1 2026	175,449	$5.49M	<0.1%	−71,866−29.1%	Reduced	Holders
Q4 2025	247,315	$7.50M	<0.1%	+247,315	New	Holders